Over the past decades, the use of ovulation inducing drugs has been increasing. A possible
causal link between fertility treatments (especially clomiphene citrate and gonadotrophins) …

OBJECTIVE: To assess the long-term effects of ovulation-stimulating drugs on the risk of
ovarian cancer. METHODS: A retrospective cohort study of 12,193 eligible study subjects …

OBJECTIVE: To critically examine the possible association between ovulation-inducing
drugs and ovarian cancer. DESIGN: Medline literature review and cross-reference of …

This large retrospective study investigating the effect of ovulation-stimulating drugs on the
subsequent risk of ovarian cancer included infertility patients from 5 large reproductive …

Although nulliparity has been extensively related to the risk of ovarian, breast and
endometrial cancers, with many studies showing the relationship largely attributable to …

OBJECTIVE: To review and critique the literature regarding ovulation induction and cancer
risk. DESIGN: Identification of relevant clinical and epidemiological literature through …

BACKGROUND: Despite the recognized role of hormones in the aetiology of breast cancer,
there has been little evaluation of hormonal preparations used to treat infertility. METHODS …

Ovulation-inducing drugs have been widely used for various types of infertility since the
beginning of 1960s and their use increases day by day parallel to the success achieved in …

Objective To review critically the published data regarding the proposed association of
ovulation induction, infertility, and an increased risk of ovarian cancer. Design A medline …

The risk of developing gynaecological cancer following ovulation induction therapy in
infertile patients is not easy to determine due to many confounding factors. These include …